Strategic Advisor, Medical Affairs, IQVIA
Sr. Principal, IQVIA
Sr. Director, Scientific Services, IQVIA
The FDA’s evolving SIUU guidance is reshaping how Medical Affairs supports pre‑launch strategy. This webinar breaks down what the new framework means for proactive scientific exchange, earlier dissemination of evidence, and compliant collaboration across Medical Affairs, RWE, and Commercial teams. Attendees will gain clarity on operational guardrails and learn how to turn regulatory guidance into a strategic advantage during pre‑launch planning.
Stay ahead of regulatory change and elevate your Medical Affairs impact by registering today.
We empower Medical Affairs with end-to-end capabilities, leveraging data, technology, and expertise to generate and disseminate evidence for improved patient outcomes.
